Cyclophosphamide metabolism in children following a 1-h and a 24-h infusion

被引:0
|
作者
Steven M. Yule
Lisa Price
Mike Cole
Andrew D.J. Pearson
Alan V. Boddy
机构
[1] Oncology/Haematology,
[2] Roche Products Ltd,undefined
[3] 40 Broadwater Road,undefined
[4] Welwyn Garden City,undefined
[5] Hertfordshire AL7 3AY,undefined
[6] UK,undefined
[7] Department of Child Health and Department of Pharmacological Sciences,undefined
[8] The Medical School,undefined
[9] University of Newcastle upon Tyne,undefined
[10] UK,undefined
[11] Department of Child Health,undefined
[12] The Medical School,undefined
[13] University of Newcastle upon Tyne,undefined
[14] UK,undefined
[15] Department of Child Health and Department of Statistics,undefined
[16] The Medical School,undefined
[17] University of Newcastle upon Tyne,undefined
[18] UK,undefined
[19] The Cancer Research Unit,undefined
[20] The Medical School,undefined
[21] University of Newcastle upon Tyne,undefined
[22] UK,undefined
来源
关键词
Autoinduction Cyclophosphamide Cytochrome P450 Drug metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: The pharmacokinetics and metabolism of cyclophosphamide (CPA) when given as a 1-h and a 24-h infusion to children were compared. Methods: Thirteen children with a variety of different malignancies received an identical dose of cyclophosphamide as a 1- and 24-h infusion. In each case the concentration of CPA and its principal metabolites were measured by a thin-layer-chromatography–photographic-densitometry technique. Results: Cyclophosphamide clearance was greater during the 24-h infusion, following time-dependent increases in the metabolism of the drug (autoinduction) (median 5.1 vs 3.1 l/h/m2: P=0.037). Autoinduction was seen in five children (38%), producing a median end of infusion concentration of 49% (range 28–89%) of the maximum and was not accompanied by an increase in the production of the principal inactive metabolites carboxyphosphamide and dechloroethylcyclophosphamide. Conclusions: These results suggest potential benefits of prolonging the infusion of CPA in clinical practice.
引用
收藏
页码:222 / 228
页数:6
相关论文
共 50 条
  • [21] COMBINATION THERAPY OF GEMCITABINE AND 24-H INFUSION OF CISPLATIN FOR ADVANCED UROTHELIAL CARCINOMAS
    Ina, K.
    Furuta, R.
    Totani, H.
    Kayukawa, S.
    Hibi, S.
    Kabeya, M.
    Sirokawa, Y.
    Koga, C.
    Kataoka, T.
    ANNALS OF ONCOLOGY, 2013, 24 : 91 - 91
  • [22] A feasibility study of 1-h paclitaxel infusion in patients with solid tumors
    Tsavaris, N
    Polyzos, A
    Kosmas, C
    Giannikos, L
    Gogas, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (04) : 353 - 357
  • [23] ENERGY-METABOLISM OF THE NEWBORN PIG DURING THE 1ST 24-H OF LIFE
    NOBLET, J
    LEDIVIDICH, J
    BIOLOGY OF THE NEONATE, 1981, 40 (3-4): : 175 - 182
  • [24] Cardiac transplantation following a 24-h preservation using a perfusion apparatus
    Tsutsumi, H
    Oshima, K
    Mohara, J
    Takeyoshi, I
    Aizaki, M
    Tokumine, M
    Matsumoto, K
    Morishita, Y
    JOURNAL OF SURGICAL RESEARCH, 2001, 96 (02) : 260 - 267
  • [25] COMPARISON OF A RAPID (2-H) VERSUS A SLOW (24-H) INFUSION OF ALENDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY
    ZYSSET, E
    AMMANN, P
    JENZER, A
    GERTZ, BJ
    PORTMANN, L
    RIZZOLI, R
    JAQUETMULLER, F
    PRYORTILLOTSON, S
    BONJOUR, JP
    BURCKHARDT, P
    BONE AND MINERAL, 1992, 18 (03): : 237 - 249
  • [26] Validity of a multisensor armband in estimating 24-h energy expenditure in children
    Dorwny, Cindy A.
    Cho, Leena
    Akohoue, Sylvie A.
    Chen, Kong Y.
    Buchowski, Maciej S.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008, 40 (04): : 699 - 706
  • [27] Adherence to 24-h movement behaviour guidelines in families with multiple children
    Tooth, Leigh R.
    Mielke, Gregore I.
    Moss, Katrina M.
    CHILD CARE HEALTH AND DEVELOPMENT, 2024, 50 (01)
  • [28] The effect of glucose infusion on glucose kinetics during a 1-h time trial
    Carter, JM
    Jeukendrup, AE
    Mann, CH
    Jones, DA
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2004, 36 (09): : 1543 - 1550
  • [29] A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion
    van Riel, J. M.
    Peters, G. J.
    Mammatas, L. H.
    Honeywell, R. J.
    Laan, A. C.
    Ruyter, R.
    van den Berg, F. G.
    Giaccone, G.
    van Groeningen, C. J.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2519 - 2527
  • [30] Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure
    Lilleberg, J.
    Laine, A.
    Palkama, T.
    Kivikko, A.
    Pohjanjousi, P.
    Kupari, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (01) : 75 - 82